Literature DB >> 26433269

Familial Incidence of Cardiovascular Malformations in Hypoplastic Left Heart Syndrome.

Angela M Kelle1, Muhammad Y Qureshi2, Timothy M Olson3, Benjamin W Eidem3, Patrick W O'Leary3.   

Abstract

Obstructive left-sided congenital heart lesions exhibit familial clustering, and familial echocardiographic screening for bicuspid aortic valve has become standard practice. Hypoplastic left heart syndrome (HLHS) is a severe left-sided obstructive lesion; however, familial screening is not universally recommended. The purpose of this study was to define the incidence of cardiovascular malformations (CVMs) in first-degree relatives of HLHS probands. First-degree relatives were screened for CVM by transthoracic echocardiography. Screening was completed in 152 family members (97 parents and 55 siblings) of 52 probands. Of these, 17 of 152 (11%) had CVM. Anomalies detected included: bicuspid aortic valve in 5 (3%), isolated dilated ascending aorta in 4 (3%), coarctation of the aorta in 1, partial anomalous pulmonary venous connection in 1, anomalous, intramural coronary artery in 1, bicuspid pulmonary valve in 1, and other anomalies in 4. Most were previously undiagnosed (11 of 17, 65%). Fourteen of 52 families (27%) had ≥1 relative with CVM. Overall, 7 of 55 siblings (13%), 5 of 46 fathers (11%) and 5 of 51 mothers (10%) had CVM. Although the incidence of CVM in first-degree relatives of HLHS probands was lower in this cohort than previously reported, it remained substantial, with at least one additional member having CVM in 27% of families. The frequent occurrence of undiagnosed CVM highlights the importance of routine familial screening in HLHS. In fact, even if screening was done in childhood, it may be appropriate to screen again in the third or fourth decade to exclude isolated enlargement of the ascending aorta.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26433269     DOI: 10.1016/j.amjcard.2015.08.045

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Potential risk factors for Ebstein anomaly, National Birth Defects Prevention Study, 1997-2011.

Authors:  Karrie F Downing; Tiffany Riehle-Colarusso; Suzanne M Gilboa; Angela E Lin; Matthew E Oster; Sarah C Tinker; Sherry L Farr
Journal:  Cardiol Young       Date:  2019-06-04       Impact factor: 1.093

Review 2.  Appropriate Use of Genetic Testing in Congenital Heart Disease Patients.

Authors:  Seiji Ito; Kimberly A Chapman; Monisha Kisling; Anitha S John
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

Review 3.  The role of glucose in physiological and pathological heart formation.

Authors:  Haruko Nakano; Viviana M Fajardo; Atsushi Nakano
Journal:  Dev Biol       Date:  2021-02-10       Impact factor: 3.148

Review 4.  Familial Screening for Left-Sided Congenital Heart Disease: What Is the Evidence? What Is the Cost?

Authors:  Daniel J Perry; Connor R Mullen; Horacio G Carvajal; Anoop K Brar; Pirooz Eghtesady
Journal:  Diseases       Date:  2017-12-08

5.  Whole exome sequencing in 342 congenital cardiac left sided lesion cases reveals extensive genetic heterogeneity and complex inheritance patterns.

Authors:  Alexander H Li; Neil A Hanchard; Dieter Furthner; Susan Fernbach; Mahshid Azamian; Annarita Nicosia; Jill Rosenfeld; Donna Muzny; Lisa C A D'Alessandro; Shaine Morris; Shalini Jhangiani; Dhaval R Parekh; Wayne J Franklin; Mark Lewin; Jeffrey A Towbin; Daniel J Penny; Charles D Fraser; James F Martin; Christine Eng; James R Lupski; Richard A Gibbs; Eric Boerwinkle; John W Belmont
Journal:  Genome Med       Date:  2017-10-31       Impact factor: 11.117

6.  Re-evaluation of hypoplastic left heart syndrome from a developmental and morphological perspective.

Authors:  A Crucean; A Alqahtani; D J Barron; W J Brawn; R V Richardson; J O'Sullivan; R H Anderson; D J Henderson; B Chaudhry
Journal:  Orphanet J Rare Dis       Date:  2017-08-10       Impact factor: 4.123

7.  Abnormal Flow Conditions Promote Endocardial Fibroelastosis Via Endothelial-to-Mesenchymal Transition, Which Is Responsive to Losartan Treatment.

Authors:  Nicholas A Oh; Xuechong Hong; Ilias P Doulamis; Elamaran Meibalan; Teresa Peiseler; Juan Melero-Martin; Guillermo García-Cardeña; Pedro J Del Nido; Ingeborg Friehs
Journal:  JACC Basic Transl Sci       Date:  2021-12-27

8.  Whole Genome Sequencing in Hypoplastic Left Heart Syndrome.

Authors:  Jeanne L Theis; Timothy M Olson
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-15

9.  Exome sequencing in multiplex families with left-sided cardiac defects has high yield for disease gene discovery.

Authors:  David M Gordon; David Cunningham; Gloria Zender; Patrick J Lawrence; Jacqueline S Penaloza; Hui Lin; Sara M Fitzgerald-Butt; Katherine Myers; Tiffany Duong; Donald J Corsmeier; Jeffrey B Gaither; Harkness C Kuck; Saranga Wijeratne; Blythe Moreland; Benjamin J Kelly; Vidu Garg; Peter White; Kim L McBride
Journal:  PLoS Genet       Date:  2022-06-23       Impact factor: 6.020

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.